VP, GPL Franchise Lead -- ICV (Immunology and Cardiovascular) at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Advanced degree in a relevant scientific field (implied by role seniority and leadership in drug development)
Extensive experience in pharmaceutical R&D, particularly in immunology and cardiovascular (ICV) areas
Proven track record in disease area strategy, portfolio management, and drug development lifecycle
Strong leadership experience managing high-performing teams of Global Program Leads
Expertise in partnering across functions (Research, Development, GPS, Commercialization, Business Development)
Demonstrated enterprise mindset for budget management, tradeoffs, and business development
Skills in strategic communication, risk assessment, and data-driven decision-making

Responsibilities

Develop end-to-end disease area portfolio strategy spanning full lifecycle in partnership with drug development functions (Strategy & Portfolio Management, Global Regulatory & Safety, Global Development Operations) and other functions (Research, Commercialization, GPS, Enterprise Strategy)
Accelerate portfolio and reduce development timelines for promising new assets while optimizing revenue and reach of marketed products
Lead all R&D business development activities for the ICV portfolio in partnership with Business Development and DD Strategy & Portfolio Management
Manage disease portfolio budget, making tradeoff decisions with enterprise mindset
Drive execution of portfolio strategy through leadership of Disease Area Global Program Leads
Lead and inspire a high-performing organization of Global Program Leaders across the Disease Area
Oversee orchestration of design and execution of globally integrated program strategies, timelines, and budgets from candidate nomination to launch, commercialization, and lifecycle management
Prioritize, synthesize, and pressure test feedback from senior leadership on program direction/outputs and coach GPLs in this skillset
Provide strategic and technical leadership to build a world-class drug development team, balancing scientific excellence and operational effectiveness
Demonstrate inspirational leadership to engage, develop, and create an inclusive/diverse environment that drives innovation
Demonstrate superior enterprise mindset and leadership maturity to shape the future of R&D
Ensure Program Leaders demonstrate must-win capabilities and partner effectively with R&D functions (e.g., Clinical Development) and across the Enterprise (e.g., Operations, GPS, Commercial)
Engage senior leaders and functional stakeholders to ensure alignment of program strategy and operational plans
Clearly communicate program risks, implications of changes in competitive landscape, and progress toward key milestones
Lead team problem-solving in delivering key data and interpretation for robust debate and rapid, data-driven decision-making
Leverage experience to efficiently integrate information from team members and facilitate rapid and objective, data-driven decisions

Skills

Portfolio Strategy

Disease Strategy

Drug Development

Immunology

Cardiovascular

Global Regulatory

Global Development Operations

Team Leadership

Commercialization

Research Partnership

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free